The FDA has approved a label expansion for Casgevy to include patients aged 2 years and older with sickle cell disease and ...

AMA recently reiterated its call for Congress to pass several reforms that would increase physician payment and improve ...

In patients with fibrodysplasia ossificans progressiva, an oral selective inhibitor of activin receptor–like kinase 2 was ...

The latest rewrite of the charter for the CDC’s influential vaccine advisory committee could fundamentally alter the panel’s ...

Adults with type 2 diabetes who were provided medically tailored healthy meals and lifestyle counseling for 6 months had a ...

Wide gaps exist in the prevalence, awareness and treatment of many cardiometabolic conditions, and policies that expand ...

A new CMS proposed rule would reduce the burden of prior authorizations by further shortening payer decision timeframes and ...

The FDA declined to approve a biologics license application for Galderma’s relabotulinumtoxinA, citing manufacturing and ...

The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale ...

When a patient with cancer tells their clinician they smoke, Andrea C. King, PhD, wants alarm bells to ring inside the exam ...

HHS Secretary Robert F. Kennedy Jr. is moving to terminate COVID-19 emergency use authorization declarations for drugs, ...

Storm chasing is often described as hours of boredom intermixed with moments of sheer terror. I fear that that metaphor is ...